On Tuesday, Sprint Corp (NYSE:S)’s shares inclined 0.46% to $4.40.
Whether you are island-hopping through the Caribbean, escaping to Fiji or touring France, your world just expanded with Sprint. Thirty-three destinations have been added to the free Sprint Open World add-on service, giving customers unlimited free texting and great rates on calls and high-speed data.
Sprint Open World
- For customers traveling frequently to Mexico, Canada and 12 countries across Latin America, Sprint Open World comprises free calling and text, plus 1GB of free data. The Latin American countries are Dominican Republic, Argentina, Brazil, Chile, Colombia, Costa Rica, El Salvador, Guatemala, Honduras, Nicaragua, Panama and Paraguay. Sprint offers free calling in more international destinations than any other carrier. T-Mobile offers free calling in two countries. AT&T and Verizon do not offer free international calling.
- In more than 50 other destinations, counting those just added to the Sprint Open World plan, texting is free, calls are just $0.20/minute, and high-speed data is only $30/GB.
Sprint Corporation, through its auxiliaries, provides various wireless and wireline communications products and services to consumers, businesses, government subscribers, and resellers in the United States, Puerto Rico, and the U.S. Virgin Islands.
Verizon Communications Inc. (NYSE:VZ)’s shares dropped -0.85% to $44.42.
It’s been about one month since the United States officially reopened its embassy in Cuba. Starting next week, Verizon Wireless customers who travel internationally can connect easily – counting talk, messaging and data – while in the Caribbean’s largest nation, through the company’s Pay-As-You-Go International Travel option.
Verizon is the first U.S.-based wireless company to offer roaming in Cuba.
The process is simple. Customers using a World Device who are traveling to Cuba can opt-in to add the Pay-As-You-Go International Travel option. While in Cuba, voice calls are $2.99 per minute, data is $2.05 per megabyte and standard international messaging rates apply. This allows customers the ability to stay connected while in Cuba.
Verizon Communications Inc., through its auxiliaries, provides communications, information, and entertainment products and services to consumers, businesses, and governmental agencies worldwide.
At the end of Tuesday’s trade, Ampio Pharmaceuticals Inc (NYSEMKT:AMPE)‘s shares surged 5.35% to $3.35.
Ampio Pharmaceuticals Inc (AMPE) a Colorado corporation and about 81.5%-owned partner of Ampio Pharmaceuticals, a Delaware corporation (the “Company”), reached and closed on an Asset Purchase Agreement (the “Purchase Agreement”) with Jazz Pharmaceuticals, Inc. (the “Seller”). Following the Purchase Agreement, Rosewind purchased from the Seller assets related to the Seller’s product known as ProstaScint (capromab pendetide), counting certain intellectual property and contracts, and the product approvals, inventory and work in progress (collectively, the “ProstaScint Business”), and assumed certain of the Seller’s liabilities, counting those related to product approvals and the sale and marketing of ProstaScint.
Rosewind paid $1.0 million at closing for the ProstaScint Business. Rosewind has also agreed to pay to the Seller an additional $500,000 payable within five days after transfer for the ProstaScint-related product inventory and $226,523 payable on September 30, 2015 (which represents a portion of certain United States Food and Drug Administration fees). Rosewind also will pay to the Seller eight percent (8%) on net sales made after October 31, 2017, payable up to a maximum aggregate payment of $2.5 million.
The Purchase Agreement contains customary representations and warranties and covenants by each party. The Purchase Agreement contains customary indemnification provisions by each party, counting, subject to certain limitations, the indemnification by each party for any losses arising out of any breach of the other party’s representations or warranties or any breach or failure to perform any of its covenants under the agreement, in addition to any liabilities arising out of the ProstaScint Business prior to the closing (as to Rosewind) and after the closing (as to the Seller).
The Purchase Agreement also provides that for a period of one year the Seller agrees to not directly or indirectly, through any of its agents or associates,
(i) compete against the ProstaScint Business, or (ii) acquire a company or business in which more than fifteen percent (15%) of such attained business’ total revenue is generated by products that compete with the ProstaScint Business.
The foregoing summary of the material terms of the Purchase Agreement does not purport to be complete and is subject to, and qualified in its entirety by, the full text of the Purchase Agreement, which is being filed as an exhibit to Rosewind’s Current Report on Form 8-K on May 27, 2015, and is incorporated by reference into this Current Report on Form 8-K.
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing therapies for the treatment of prevalent inflammatory conditions in the United States. The company is developing compounds that decrease inflammation by inhibiting specific pro-inflammatory compounds by affecting specific pathways at the protein expression and at the transcription level; activating specific phosphatase or depletion of the accessible phosphate needed for the inflammation process; and decreasing vascular permeability.
Texas Instruments Incorporated (NASDAQ:TXN), ended its Tuesday’s trading session with -1.77% loss, and closed at $46.61.
Texas Instruments Incorporated (TI) (TXN) said it will raise its quarterly cash dividend by 12 percent, from $0.34 per share to $0.38, or $1.52 annualized. The higher dividend will be payable November 16, 2015, to stockholders of record on October 30, 2015, contingent upon formal declaration by the board of directors at its regular meeting in October.
The board of directors also authorized the company to repurchase an additional $7.5 billion of its common stock over time. This is in addition to about $1.8 billion of formerly authorized repurchases that remained at the end of June 2015.
Dividend enhances and share repurchases are both part of TI’s capital administration strategy. The company has raised dividends each year for the past 12 years, and through comprising share repurchases has reduced outstanding shares by 40 percent since the starting of 2005.
Texas Instruments Incorporated designs, manufactures, and sells semiconductors to electronics designers and manufacturers worldwide. It operates through two segments, Analog and Embedded Processing. The Analog segment offers high volume analog and logic products for automotive safety devices, touch screen controllers, low voltage motor drivers, and integrated motor controllers; and power administration products to enhance the efficiency of powered devices using battery administration solutions, portable power conversion devices, power supply controls, and point-of-load products.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
